CCC
SYNA icon

Crescent Capital Consulting’s Synaptics SYNA Stock Holding History

Crescent Capital Consulting’s Portfolio SYNA Stock Details SYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$17K Hold
59
– – ﹤0.01% 365
2021
Q3 		$11K Hold
59
– – ﹤0.01% 417
2021
Q2 		$9K Buy
+59
New +$7.98K ﹤0.01% 380

Other funds holding SYNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crescent Capital Consulting's SYNA Position: Q4 2021 in Review

Crescent Capital Consulting held its Synaptics (SYNA) position steady in Q4 2021 at 59 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Crescent Capital Consulting first reported a position in SYNA in Q2 2021 and has held it in 3 quarters since. 363 funds tracked by Wall St. Rank hold SYNA as of Q4 2021.

  • Crescent Capital Consulting held 59 shares of Synaptics worth $17K as of Q4 2021.
  • Crescent Capital Consulting left its Synaptics share count unchanged in Q4 2021.
  • Synaptics made up ﹤0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #365 holding.
  • Crescent Capital Consulting first reported a position in Synaptics in Q2 2021 and has held it in 3 quarters since.
  • 363 funds tracked by Wall St. Rank held Synaptics as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.